NATALIA KHALAF to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications NATALIA KHALAF has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.499
-
Statin use and pancreatic cancer risk in two prospective cohort studies. J Gastroenterol. 2018 Aug; 53(8):959-966.
Score: 0.345
-
Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. Clin Gastroenterol Hepatol. 2018 08; 16(8):1300-1306.e3.
Score: 0.087
-
Statin use is associated with a decreased risk of Barrett's esophagus. Gastroenterology. 2014 Aug; 147(2):314-23.
Score: 0.067